Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-17-003845
Filing Date
2017-08-11
Accepted
2017-08-11 13:57:59
Documents
55
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q merion_10q.htm 10-Q 328771
2 CERTIFICATION merion_ex311.htm EX-31.1 8790
3 CERTIFICATION merion_ex321.htm EX-32.1 3045
  Complete submission text file 0001477932-17-003845.txt   2486019

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT merion-20170630.xml EX-101.INS 464977
5 XBRL TAXONOMY EXTENSION SCHEMA merion-20170630.xsd EX-101.SCH 38135
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE merion-20170630_cal.xml EX-101.CAL 40206
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE merion-20170630_def.xml EX-101.DEF 73892
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE merion-20170630_lab.xml EX-101.LAB 195902
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE merion-20170630_pre.xml EX-101.PRE 162555
Mailing Address 9550 FLAIR DRIVE #308 EL MONTE CA 91731
Business Address 9550 FLAIR DRIVE #308 EL MONTE CA 91731 626 448 3737
Merion, Inc. (Filer) CIK: 0001517498 (see all company filings)

EIN.: 208280840 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-173681 | Film No.: 171024221
SIC: 5122 Wholesale-Drugs, Proprietaries & Druggists' Sundries